Adam Leo Stone - Jun 23, 2022 Form 4 Insider Report for LianBio (LIAN)

Role
Director
Signature
/s/ Angela Chen, Attorney-in-Fact
Stock symbol
LIAN
Transactions as of
Jun 23, 2022
Transactions value $
$0
Form type
4
Date filed
6/27/2022, 05:36 PM
Previous filing
Jun 9, 2022
Next filing
Dec 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIAN Stock Option (Right to Buy) Award $0 +36.3K $0.00 36.3K Jun 23, 2022 Ordinary Shares 36.3K $2.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option shall vest and become exercisable in full on June 23, 2023, the first anniversary of the grant date, subject to the Reporting Person providing continuous service to the Issuer through such date.